Guggenheim cuts Eloxx Pharmaceuticals price target to $40 from $43
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Theta Gold Mines Draws First US$37 Million Under US$90 Million Bond
The company says the drawdown followed an US$18.6 million equity raising.
L impact | EQUITY | Oct 30, 2026, 01:59 AM UTC
Shengyi Technology shares fall 8.7% as Jefferies cuts target
Shengyi Technology shares fell 8.7% to 85.9 yuan after opening down 4.9%, while Jefferies lowered its price target.
M impact | EQUITY | Oct 30, 2026, 01:58 AM UTC
China 5G Communications Index Falls 5.7% to Near 11-Month Low
The CSI 5G Communications Index fell 5.7% in early trading, reaching its lowest level in nearly 11 months.
M impact | EQUITY | Oct 30, 2026, 01:56 AM UTC
Taiwan Benchmark Index Falls as Much as 3.5% to 44,726.26
Taiwan's benchmark stock index fell as much as 3.5% to 44,726.26, its lowest level since August 25.
M impact | EQUITY | Oct 30, 2026, 01:56 AM UTC
Beach Cities Commercial Bank Announces Third-Quarter 2026 Results
M impact | EQUITY | Oct 30, 2026, 01:55 AM UTC
Nikkei Index Falls 3%
M impact | EQUITY | Oct 30, 2026, 01:54 AM UTC